MCRB
Companies
NASDAQ
Seres Therapeutics Inc.
Health Care
$7.73
-$8.89 (-53.49%)
Price Chart
Overview
About MCRB
seres therapeutics is a clinical stage biotherapeutic company focused on discovering and developing ecobiotic™ therapeutic products, novel drugs to treat important diseases by targeting the underlying biology of the human microbiome. founded by flagship venturelabs, seres is pioneering the first therapeutics that catalyze a shift to health by augmenting the biology of the microbiome. current candidates span infectious, metabolic, and inflammatory diseases. for more information, please visit http://serestherapeutics.com/.
Market Cap
$93.0M
Volume
6.2M
Avg. Volume
6.4M
P/E Ratio
-1.0865453
Dividend Yield
0.00%
Employees
359.0
Company Information
Latest News for MCRB
Risk & Correlation Analysis
Market Correlation
1.94
High Correlation
Volatility
High (1.00)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
Medium Sensitivity
GDP Growth
Low Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Medium Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, MCRB shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$93.0M
Volume6.2M
P/E Ratio-1.09
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
March 13, 2025Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025